Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Wegovy a day early won't automatically harm you, but it isn't recommended and the prescribing guidance is clear: semaglutide injections are designed for a fixed once-weekly schedule, and shifting that cycle without clinical input can disrupt how the medicine works. Here is what the official information says, and what to do instead.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Wegovy prescribing schedule is grounded in the pharmacokinetics of semaglutide: the medicine accumulates slowly and reaches steady-state concentration over several weeks of once-weekly dosing. The NHS medicines page for semaglutide is explicit that injections should be given on the same day each week, and that the day can be changed provided at least 48 hours separate the previous dose from the new one.
That 48-hour minimum is the floor, not the target. The 7-day rhythm exists precisely because the medicine's half-life (roughly one week) is matched to weekly dosing. Compress the gap consistently and you risk higher peak concentrations, which rarely add to weight-loss benefit but do raise the likelihood of nausea, vomiting and other gastrointestinal effects that tend to be worst at higher or more frequent exposures.
So if you are wondering whether taking your Wegovy shot early by a day is a serious error: a single occurrence, with more than 48 hours since the last dose, is generally not considered dangerous. But doing it regularly, or doing it without knowing how many hours have passed, puts you outside the intended schedule.
The most commonly reported side effects of semaglutide are gastrointestinal: nausea, vomiting, diarrhoea and constipation feature prominently across the STEP trial programme, including STEP 1, published in the New England Journal of Medicine, which randomised over 1,900 adults and found around 15% average weight loss over 68 weeks at the 2.4 mg maintenance dose. Adverse events in those trials were most common early in treatment and after dose increases — exactly the conditions a shortened interval can mimic.
When a dose arrives sooner than expected, semaglutide levels in the body rise before the previous dose has had its full week to clear. The practical result is not extra weight loss; the medicine's effect on appetite and gastric emptying is already working. What you are adding is drug exposure without proportionate benefit, which is a poor trade.
If you are mid-titration (on 0.25 mg or 0.5 mg heading toward maintenance) the effect of timing errors tends to be more noticeable than on a settled maintenance dose. The Wegovy treatment overview has more on how the titration ladder is structured and what each stage is for.
Sometimes life forces a scheduling change: a bank holiday, a long weekend away, a procedure that means no injections for a few days. These are real situations, not edge cases.
The licensed guidance allows a one-off day change provided the new injection falls at least 48 hours after the previous one and no more than one week ahead of the dose that would otherwise be next. Plan the shift once, then hold the new day consistently going forward. That is the adjustment a prescriber can help you plan in a single conversation rather than guessing.
For context on what a permanent change looks like in practice: if your usual day is Monday but you need to move to Saturday, you would take the transition dose on Saturday so long as your last Monday injection was at least two days earlier, think of it as a diary reschedule with a clinical check, not unlike moving a standing appointment. From that Saturday onward, Saturday becomes your day.
If you are considering switching days and want to understand what taking Wegovy a day early actually involves versus shifting by two days, the detail on shifting the injection by two days covers the timing arithmetic more granularly. For questions about your own situation, the support team can connect you with a prescriber seven days a week.
If you have already taken your Wegovy shot early, the most practical next step is to note the date and time, then count forward seven days to set your new injection day. The Wegovy SmPC on the eMC provides the full dosing and timing detail; the key principle from it is that the next dose should follow no sooner than 48 hours after the early one.
Watch for any uptick in gastrointestinal symptoms over the next 24 to 48 hours. Mild nausea is not unusual. If you are still unsure whether you can take Wegovy a day early in your specific circumstances, or if symptoms are severe or persistent, contact a clinician rather than waiting. Our prescribers are available through the nume FAQ hub and the aftercare line seven days a week.
On the broader question of cost and ongoing access to private Wegovy treatment (including what a monitored private prescription includes) the Wegovy access and pricing page sets out the options clearly. And if you are still at the stage of deciding whether semaglutide is the right treatment for you, starting a free consultation is the way to get a clinician's view on your full picture.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.